Piers Ingram - CEO & Co-Founder @ Hummingbird Bioscience

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Piers Ingram is based out of Singapore and is the CEO and Co-Founder of Callio Therapeutics. Piers attended Imperial College London.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Hillstar Bio	Hummingbird Bioscience	—	Series A - Hillstar Bio	obfuscated obfuscation

Number of Current Jobs

has

current jobs as

CEO & Co-Founder

and

CEO & Co-Founder

Number of Current Board & Advisor Roles

is the

Board Member

Hub Name	CB Rank (Hub)
Asia Late Stage Companies	8,240
Asia-Pacific (APAC) Health Care Companies with Late Stage Venture Funding	42,919
Singapore Companies With More Than 10 Employees (Top 10K)	10,985
Association of Southeast Asian Nations (ASEAN) Companies With More Than $10M in Revenue (Top 10K)	10,258
Kiwoom Investment Portfolio Companies	29,202
Biotechnology Late Stage Companies With More Than $10M in Revenue	32,828
Association of Southeast Asian Nations (ASEAN) Companies With Fewer Than 100 Employees (Top 10K)	2,708
Singapore Companies With More Than 50 Employees	12,566
Southeast Asia Companies With Less Than $50M in Revenue (Top 10K)	5,604
Southeast Asia Health Care Companies	18,942